Evaluation of Dentin Hypersensitivity Using Glass Ionomer Cements

• Status: Completed
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this randomized, double-blind, split-mouth clinical trial is to evaluate and compare the desensitizing efficacies of the resin-modified glass ionomer cement ClinproTM XT (3M ESPE, Minnesota, USA) and the conventional glass ionomer cement Vidrion R (SS White, Gloucester, UK) at 2-year follow-up.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Federal University of Pelotas
• Treatments: Methamphetamine

Criteria

Inclusion Criteria:

• Male and female subjects between 18 and 70 years old

• At least 2 teeth with dentin hypersensitivity in two different hemiarchs

• Dental elements with hypersensitivity without any pulp alteration

• People who are not taking any medication and women who are not pregnant

• Patients without eating disorders or very acidic diets.

Exclusion Criteria:

• Teeth with hypersensitivity that presented extensive or unsatisfactory restorations, fractures, periodontal alterations, caries lesions, orthodontic brackets, endodontic treatments, pulp alterations.

• Subjects who received any desensitizing therapy during the last 3 months

• Subjects being under analgesics/anti-inflammatory drugs at the time of the study

• Teeth with hypersensitivity and non-carious cervical lesions